The prevention of severe COVID-19 in the elderly

Early administration of plasma with high titers of antibody against SARS-CoV2 to infected seniors reduced progression to severe COVID-19 by 48%. Selecting plasma with IgG titers above a median of 1:3,200 increased protection to 73%. Read the full study right here.


© 2021 by Covid Plasma Initiative Foundation

The Yitzchok Lebovits COVID Plasma Initiative is dedicated in memory of R’ Yitzchok a"h Ben R’ Moshe Eliezer y"blt, who recently passed away. R' Yitzchok was a brother of Chaim Lebovits who has been a driving force behind every aspect of this initiative to bring this life-saving therapy to the people who need it.